Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ADRIENNE R HOLLANDER

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1417994633
CMS profile
337410
Location
VOORHEES, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$35,125.74

134 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $19,008.45 36
ABBVIE INC. $9,089.07 36
Amgen Inc. $6,396.92 25
UCB, Inc. $201.87 5
E.R. Squibb & Sons, L.L.C. $183.17 18
Novartis Pharmaceuticals Corporation $127.75 7
GlaxoSmithKline, LLC. $46.77 3
Organon LLC $36.57 2
Alexion Pharmaceuticals, Inc. $18.61 1
AstraZeneca Pharmaceuticals LP $16.56 1

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ADRIENNE R HOLLANDER

NPI 1417994633 · CMS profile ID 337410

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

VOORHEES, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417994633?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ADRIENNE R HOLLANDER, NPI 1417994633, CMS profile ID 337410. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417994633?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ADRIENNE R HOLLANDER, NPI 1417994633, CMS profile ID 337410. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417994633?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ADRIENNE R HOLLANDER, NPI 1417994633, CMS profile ID 337410, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–134 of 134 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1417994633?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

134 matching records · $35,125.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 134 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–134 of 134.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $16.9804/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527574 CMS
ABBVIE INC. $5.9904/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057826 CMS
Janssen Biotech, Inc. $1,853.0004/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1175237925 CMS
ABBVIE INC. $2,625.0004/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1202057824 CMS
ABBVIE INC. $16.5104/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057822 CMS
AstraZeneca Pharmaceuticals LP $16.5604/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206984158 CMS
Amgen Inc. $2,400.0004/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226913288 CMS
ABBVIE INC. $11.9504/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057818 CMS
ABBVIE INC. $4.3704/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057820 CMS
GlaxoSmithKline, LLC. $13.5904/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190343404 CMS
Amgen Inc. $124.7104/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527582 CMS
E.R. Squibb & Sons, L.L.C. $2.3004/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184591581 CMS
ABBVIE INC. $12.6803/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057816 CMS
Janssen Biotech, Inc. $17.4303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175236475 CMS
ABBVIE INC. $85.6203/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057814 CMS
Amgen Inc. $15.3803/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527572 CMS
ABBVIE INC. $18.1003/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057812 CMS
ABBVIE INC. $4.9903/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057810 CMS
Amgen Inc. $16.6503/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527578 CMS
Novartis Pharmaceuticals Corporation $20.1903/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200358878 CMS
ABBVIE INC. $18.4903/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057808 CMS
E.R. Squibb & Sons, L.L.C. $25.3003/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184591557 CMS
E.R. Squibb & Sons, L.L.C. $21.0002/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184591549 CMS
Amgen Inc. $15.2202/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527586 CMS
Amgen Inc. $600.0002/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1226908236 CMS
ABBVIE INC. $17.5202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057806 CMS
ABBVIE INC. $2.1402/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057802 CMS
ABBVIE INC. $15.7102/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057804 CMS
Janssen Biotech, Inc. $17.2201/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175236842 CMS
Amgen Inc. $15.7201/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228527584 CMS
Janssen Biotech, Inc. $121.5601/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175237713 CMS
ABBVIE INC. $15.6201/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202057800 CMS
Janssen Biotech, Inc. $10.4401/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175237621 CMS
Novartis Pharmaceuticals Corporation $17.3001/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200358866 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $72,971.42 90
PY2020 $50,856.39 24
PY2021 $18,954.48 38
PY2022 $7,466.00 31
PY2023 $15,487.49 36
PY2024 $12,868.30 49
PY2025 $35,125.74 134

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $18,419.98 15
PY2024 Principal investigator $25,914.61 20
PY2023 Principal investigator $54,834.61 40
PY2022 Principal investigator $47,285.49 34
PY2021 Principal investigator $16,442.46 34
PY2020 Recipient $1,200.00 1
PY2020 Principal investigator $29,465.30 14
PY2019 Principal investigator $34,739.99 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $672.00 12/04/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202527028
Principal investigator 1 ABBVIE INC. $1,139.50 11/04/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202520877
Principal investigator 1 ABBVIE INC. $1,621.85 10/09/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202515599
Principal investigator 1 ABBVIE INC. $594.45 09/03/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202507765
Principal investigator 1 ABBVIE INC. $339.40 08/05/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202501810
Principal investigator 1 ABBVIE INC. $333.30 07/02/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202495665
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $3,014.78 06/25/2025 Non-covered Recipient Entity
Trabecular Medical Group LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435282
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $67.34 06/09/2025 Non-covered Recipient Entity
Trabecular Medical Group LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435302
Principal investigator 1 ABBVIE INC. $2,072.20 06/03/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202487697
Principal investigator 1 ABBVIE INC. $1,549.20 05/06/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202482119
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,820.16 04/23/2025 Non-covered Recipient Entity
Trabecular Medical Group LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435289
Principal investigator 1 ABBVIE INC. $200.80 04/03/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202473301
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $131.24 03/10/2025 Non-covered Recipient Entity
Trabecular Medical Group LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435297
Principal investigator 1 ABBVIE INC. $737.30 02/05/2025 Non-covered Recipient Entity
TRABECULAR MEDICAL GROUP LLC
M15-998 - A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202444244
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $4,126.46 01/27/2025 Non-covered Recipient Entity
Trabecular Medical Group LLC
INSPIRE LTE study No dispute reported 06/30/2026 1246435292